Position in ERAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,868,074
+$6,966,884 QoQ
Shares Held
756,991
+77.5% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#50
of 257 holders
Holding Since
Mar 2022
13 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,683,134 across 266 Biotechnology names. ERAS ranks #57 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in ERAS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,868,074 | 756,991 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $6,901,190 | 426,526 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $230,491 | 61,960 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,146,699 | 526,009 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $2,634,519 | 2,074,425 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,777,026 | 2,027,027 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $5,087,837 | 2,027,027 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $8,265,694 | 3,027,727 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $8,666,804 | 3,672,375 | Shares | Other | 2024-08-14 | |
| 2023-12-31 | $1,336,154 | 627,303 | Shares | Other | 2024-02-14 | |
| 2023-03-31 | $2,179,408 | 724,056 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $1,183,250 | 274,536 | Shares | Other | 2023-02-14 | |
| 2022-03-31 | $98,048 | 11,401 | Shares | Other | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||